TRAW Traws Pharma, Inc.
Nasdaq · SEC CIK 1130598 · EDGAR
- Bought, last 12 months
- $998.2K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 114 since 2021-07-30, latest 2026-07-16 12:39
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | $998.2K | — |
| Parker Charles Nolan | CFO | — | — |
| Redfield Robert | Chief Medical Off | — | — |
| Pauza Charles David | CSO Virology | — | — |
| Savchuk Nikolay | COO, Dir | — | — |
| Clarke Trafford | Dir | — | — |
| Shoemaker Mary Teresa | Dir | — | — |
| Dukes Iain D. | CEO, Dir | — | — |
| Leaman John Harold | Dir | — | — |
| CAUTREELS WERNER | Dir | — | — |
Transactions 60
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-04-28 21:41 | 2026-04-16 | TRAW | ORBIMED ADVISORS LLC | 10% | P - Purchase | $1.67 | +597.7K | 1.20M | +99% | +$998.2K |
| D | 2026-04-08 14:47 | 2025-12-12 | TRAW | Parker Charles Nolan | CFO | A - Grant | $0.00 | +15.4K | 15.4K | New | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | CAUTREELS WERNER | Dir | A - Grant | $0.00 | +4,874 | 109.2K | +5% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Shoemaker Mary Teresa | Dir | A - Grant | $0.00 | +6,157 | 6,292 | +4,561% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Clarke Trafford | Dir | A - Grant | $0.00 | +6,157 | 6,157 | New | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Redfield Robert | Chief Medical Off | A - Grant | $0.00 | +16.4K | 113.9K | +17% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Leaman John Harold | Dir | A - Grant | $0.00 | +4,058 | 4,058 | New | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Pauza Charles David | CSO Virology | A - Grant | $0.00 | +18.5K | 116.0K | +19% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Savchuk Nikolay | COO, Dir | A - Grant | $0.00 | +16.4K | 150.6K | +12% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | STOVER JACK E | Dir | A - Grant | $0.00 | +6,157 | 6,165 | +76,962% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Dukes Iain D. | CEO, Dir | A - Grant | $0.00 | +36.9K | 171.1K | +28% | $0 |
| D | 2025-04-08 | 2025-04-02 | TRAW | Savchuk Nikolay | COO, 10% | J - Other | — | -605.5K | 0 | -100% | — |
| D | 2025-02-19 | 2025-02-18 | TRAW | CAUTREELS WERNER | CEO, Dir | M - OptEx | $0.01 | +96.3K | 104.3K | +1,204% | +$963.48 |
| A | 2024-08-07 | 2024-04-01 | TRAW | Savchuk Nikolay | COO, Dir | A - Grant | — | +67.5K | 134.2K | +101% | — |
| A | 2024-08-07 | 2024-04-01 | TRAW | Dukes Iain D. | Executive COB, Dir | A - Grant | — | +67.5K | 134.2K | +101% | — |
| D | 2024-06-20 | 2024-06-18 | TRAW | Guerin Mark Patrick | CFO | F - Tax | $0.47 | -2,221 | 39.3K | -5% | -$1,044 |
| D | 2024-06-20 | 2024-06-10 | TRAW | Guerin Mark Patrick | CFO | M - OptEx | — | +5,500 | 41.5K | +15% | — |
| D | 2024-04-03 | 2024-04-01 | TRAW | Pauza Charles David | CSO Virology | A - Grant | — | +97.5K | 97.5K | New | — |
| DI | 2024-04-03 | 2024-04-01 | TRAW | Dukes Iain D. | Executive COB, Dir | A - Grant | — | +1.65M | 1.65M | New | — |
| DM | 2024-04-03 | 2024-04-01 | TRAW | Dukes Iain D. | Executive COB, Dir | A - Grant | — | +134.2K | 66.7K | New | — |
| 2024-04-03 | 2024-04-01 | TRAW | CAUTREELS WERNER | CEO, Dir | A - Grant | — | +200.0K | 200.0K | New | — | |
| DMI | 2024-04-03 | 2024-04-01 | TRAW | Savchuk Nikolay | COO, Dir | A - Grant | — | +2.53M | 1.65M | New | — |
| DM | 2024-04-03 | 2024-04-01 | TRAW | Savchuk Nikolay | COO, Dir | A - Grant | — | +134.2K | 134.2K | New | — |
| 2024-04-03 | 2024-04-01 | TRAW | Redfield Robert | Acting Chief Medical Off | A - Grant | — | +97.5K | 97.5K | New | — | |
| D | 2024-03-15 | 2024-03-14 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $0.9 | -8,727 | 74.8K | -10% | -$7,854 |
| D | 2024-03-15 | 2024-03-13 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +23.1K | 83.5K | +38% | — |
| D | 2024-03-15 | 2024-03-13 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +8,666 | 38.6K | +29% | — |
| D | 2024-03-15 | 2024-03-14 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $0.9 | -2,591 | 36.0K | -7% | -$2,332 |
| D | 2024-02-09 | 2024-02-07 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $0.67 | -2,443 | 29.9K | -8% | -$1,637 |
| D | 2024-02-09 | 2024-02-07 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +6,900 | 32.3K | +27% | — |
| D | 2024-02-09 | 2024-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $0.67 | -9,212 | 60.4K | -13% | -$6,172 |
| D | 2024-02-09 | 2024-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +21.3K | 69.6K | +44% | — |
| D | 2023-08-04 | 2023-08-02 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +12.6K | 53.0K | +31% | — |
| D | 2023-08-04 | 2023-08-03 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $1.01 | -4,744 | 48.3K | -9% | -$4,791 |
| D | 2023-08-04 | 2023-08-02 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +4,750 | 26.9K | +21% | — |
| D | 2023-08-04 | 2023-08-03 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $1.02 | -1,422 | 25.4K | -5% | -$1,450 |
| D | 2023-06-13 | 2023-06-12 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +5,500 | 23.7K | +30% | — |
| D | 2023-06-13 | 2023-06-12 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $1.14 | -1,575 | 22.1K | -7% | -$1,795 |
| D | 2023-02-08 | 2023-02-07 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $1.36 | -1,785 | 18.2K | -9% | -$2,428 |
| D | 2023-02-08 | 2023-02-07 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +6,900 | 20.0K | +53% | — |
| D | 2023-02-08 | 2023-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +21.3K | 47.5K | +82% | — |
| D | 2023-02-08 | 2023-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $1.36 | -6,977 | 40.5K | -15% | -$9,489 |
| D | 2023-02-08 | 2023-02-07 | TRAW | Gelder Mark S. MD | Chief MEDICAL Off | F - Tax | $1.36 | -1,242 | 10.5K | -11% | -$1,689 |
| D | 2023-02-08 | 2023-02-07 | TRAW | Gelder Mark S. MD | Chief MEDICAL Off | M - OptEx | — | +5,833 | 11.7K | +99% | — |
| D | 2022-08-04 | 2022-08-03 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $1.32 | -4,562 | 26.1K | -15% | -$6,022 |
| D | 2022-08-04 | 2022-08-02 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +12.6K | 30.7K | +69% | — |
| D | 2022-08-04 | 2022-08-02 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +4,750 | 14.4K | +49% | — |
| D | 2022-08-04 | 2022-08-03 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $1.32 | -1,355 | 13.1K | -9% | -$1,789 |
| D | 2022-08-04 | 2022-08-02 | TRAW | Gelder Mark S. MD | Chief MEDICAL Off | M - OptEx | — | +4,650 | 7,031 | +195% | — |
| D | 2022-08-04 | 2022-08-03 | TRAW | Gelder Mark S. MD | Chief MEDICAL Off | F - Tax | $1.32 | -1,135 | 5,896 | -16% | -$1,498 |
| 2022-01-31 | 2022-01-28 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $1.67 | +1,500 | 24.5K | +7% | +$2,505 | |
| 2022-01-24 | 2022-01-21 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $2.02 | +1,500 | 23.0K | +7% | +$3,030 | |
| 2022-01-18 | 2022-01-14 | TRAW | OLER ABRAHAM N. | SVP CORP DEV, GEN COUNSEL | P - Purchase | $2.20 | +1,500 | 21.5K | +7% | +$3,300 | |
| 2022-01-10 | 2022-01-07 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $2.39 | +1,500 | 20.0K | +8% | +$3,585 | |
| 2021-11-23 | 2021-11-19 | TRAW | OLER ABRAHAM N. | SVP CORP DEV, GEN COUNSEL | P - Purchase | $3.16 | +1,000 | 18.5K | +6% | +$3,160 | |
| D | 2021-11-19 | 2021-11-18 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | X - OptEx | $3.00 | +5,000 | 17.5K | +40% | +$15.0K |
| 2021-09-29 | 2021-09-28 | TRAW | Gelder Mark S. MD | Chief Medical Off | P - Purchase | $4.20 | +2,381 | 2,381 | New | +$10.0K | |
| 2021-09-29 | 2021-09-28 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $4.20 | +2,381 | 12.5K | +23% | +$10.0K | |
| 2021-09-28 | 2021-09-28 | TRAW | MARINO JAMES J | Dir | P - Purchase | $4.20 | +5,952 | 21.3K | +39% | +$25.0K | |
| 2021-09-28 | 2021-09-28 | TRAW | Fruchtman Steven M | Pres, Chief Executive Off, Dir | P - Purchase | $4.20 | +2,381 | 18.1K | +15% | +$10.0K |